MedTrace Logo

Study of a Sleep Apnea System for the Treatment of Obstructive Sleep Apnea

NCT01146782 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 367

Last updated 2014-06-30

Study results available
· View outcomes & findings →

Summary

This is a prospective study of the Attune Sleep Apnea System for the treatment of obstructive sleep apnea. The objective of the study is to demonstrate safety and effectiveness of the Attune Sleep Apnea System to support FDA marketing clearance of the device.

Conditions

Interventions

DEVICE

Attune Sleep Apnea System

Console and mouthpiece sleep apnea system

Sponsors & Collaborators

  • ApniCure, Inc.

    lead INDUSTRY

Principal Investigators

  • Ian Colrain, PhD · Stanford Reasearch Institute (SRI)

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01146782 on ClinicalTrials.gov